In conclusion, we found that UBR7 is depleted in gemcitabine-resistant PDAC and further found that depleted UBR7 stabilizes PRMT5 to increase pancreatic cancer cell and Treg cell glycolysis, leading to pancreatic cancer progression and an immunosuppressive microenvironment. Here, UBR7 is linked to familial pancreatic carcinoma.